212 related articles for article (PubMed ID: 16979438)
21. Numerical assessment of radiation binary targeted therapy for HER-2 positive breast cancers: advanced calculations and radiation dosimetry.
Sztejnberg Gonçalves-Carralves ML; Jevremovic T
Phys Med Biol; 2007 Jul; 52(14):4245-64. PubMed ID: 17664606
[TBL] [Abstract][Full Text] [Related]
22. S-factor calculations for mouse models using Monte-Carlo simulations.
Bitar A; Lisbona A; Bardiès M
Q J Nucl Med Mol Imaging; 2007 Dec; 51(4):343-51. PubMed ID: 17538523
[TBL] [Abstract][Full Text] [Related]
23. Therapy of ankylosing spondylitis with 224Ra-radium chloride: dosimetry and risk considerations.
Lassmann M; Nosske D; Reiners C
Radiat Environ Biophys; 2002 Sep; 41(3):173-8. PubMed ID: 12373325
[TBL] [Abstract][Full Text] [Related]
24. Internal dosimetry in the use of radiopharmaceuticals in therapy--science at a crossroads?
Stabin MG
Cancer Biother Radiopharm; 1999 Apr; 14(2):81-9. PubMed ID: 10850291
[TBL] [Abstract][Full Text] [Related]
25. Whole-body clearance kinetics and external dosimetry of 131I-3F8 monoclonal antibody for radioimmunotherapy of neuroblastoma.
Dauer LT; St Germain J; Williamson MJ; Zanzonico P; Modak S; Cheung NK; Divgi C
Health Phys; 2007 Jan; 92(1):33-9. PubMed ID: 17164597
[TBL] [Abstract][Full Text] [Related]
26. 1-11C-methyl-4-piperidinyl-N-butyrate radiation dosimetry in humans by dynamic organ-specific evaluation.
Virta JR; Tolvanen T; Någren K; Brück A; Roivainen A; Rinne JO
J Nucl Med; 2008 Mar; 49(3):347-53. PubMed ID: 18287260
[TBL] [Abstract][Full Text] [Related]
27. Implications of nonuniform tumor doses for radioimmunotherapy.
O'Donoghue JA
J Nucl Med; 1999 Aug; 40(8):1337-41. PubMed ID: 10450686
[TBL] [Abstract][Full Text] [Related]
28. Monte Carlo simulations of dose distributions with necrotic tumor targeted radioimmunotherapy.
Penfold SN; Brown MP; Staudacher AH; Bezak E
Appl Radiat Isot; 2014 Aug; 90():40-5. PubMed ID: 24685493
[TBL] [Abstract][Full Text] [Related]
29. Systemic targeted radionuclide therapy: potential new areas.
Wong JY
Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S74-82. PubMed ID: 16979445
[TBL] [Abstract][Full Text] [Related]
30. Determination of individual organ masses for (90)Y-anti-CD66 radioimmunotherapy: influence on therapy planning.
Kull T; Kletting P; Reske SN; Glatting G
Z Med Phys; 2011 Dec; 21(4):305-9. PubMed ID: 21719265
[TBL] [Abstract][Full Text] [Related]
31. Absorbed doses for internal radiotherapy from 22 beta-emitting radionuclides: beta dosimetry of small spheres.
Bardiès M; Chatal JF
Phys Med Biol; 1994 Jun; 39(6):961-81. PubMed ID: 15551573
[TBL] [Abstract][Full Text] [Related]
32. Internal microdosimetry for single cells in radioimmunotherapy of B-cell lymphoma.
Hindorf C; Emfietzoglou D; Lindén O; Kostarelos K; Strand SE
Cancer Biother Radiopharm; 2005 Apr; 20(2):224-30. PubMed ID: 15869460
[TBL] [Abstract][Full Text] [Related]
33. Treatment planning in molecular radiotherapy.
Glatting G; Bardiès M; Lassmann M
Z Med Phys; 2013 Dec; 23(4):262-9. PubMed ID: 23597414
[TBL] [Abstract][Full Text] [Related]
34. Clinically useful marrow dosimetry for targeted radionuclide therapy.
Shen S; Meredith RF
Cancer Biother Radiopharm; 2005 Apr; 20(2):119-22. PubMed ID: 15869444
[No Abstract] [Full Text] [Related]
35. Influence of total-body mass on the scaling of S-factors for patient-specific, blood-based red-marrow dosimetry.
Traino AC; Ferrari M; Cremonesi M; Stabin MG
Phys Med Biol; 2007 Sep; 52(17):5231-48. PubMed ID: 17762083
[TBL] [Abstract][Full Text] [Related]
36. Radiopharmaceuticals for nuclear cardiology: radiation dosimetry, uncertainties, and risk.
Stabin MG
J Nucl Med; 2008 Sep; 49(9):1555-63. PubMed ID: 18765586
[TBL] [Abstract][Full Text] [Related]
37. Single-dose versus fractionated radioimmunotherapy: model comparisons for uniform tumor dosimetry.
O'Donoghue JA; Sgouros G; Divgi CR; Humm JL
J Nucl Med; 2000 Mar; 41(3):538-47. PubMed ID: 10716330
[TBL] [Abstract][Full Text] [Related]
38. [Determination of organ doses and effective doses in radiooncology].
Roth J; Martinez AE
Strahlenther Onkol; 2007 Jul; 183(7):392-7. PubMed ID: 17609873
[TBL] [Abstract][Full Text] [Related]
39. Uncertainties in internal dose calculations for radiopharmaceuticals.
Stabin MG
J Nucl Med; 2008 May; 49(5):853-60. PubMed ID: 18413398
[TBL] [Abstract][Full Text] [Related]
40. From imaging to dosimetry and biological effects.
Konijnenberg M
Q J Nucl Med Mol Imaging; 2011 Feb; 55(1):44-56. PubMed ID: 21386784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
